ATE189261T1 - Bifunktionelle urokinasevarianten mit verbesserten fibrinolytischen eigenschaften und thrombinhemmender wirkung - Google Patents

Bifunktionelle urokinasevarianten mit verbesserten fibrinolytischen eigenschaften und thrombinhemmender wirkung

Info

Publication number
ATE189261T1
ATE189261T1 AT94108872T AT94108872T ATE189261T1 AT E189261 T1 ATE189261 T1 AT E189261T1 AT 94108872 T AT94108872 T AT 94108872T AT 94108872 T AT94108872 T AT 94108872T AT E189261 T1 ATE189261 T1 AT E189261T1
Authority
AT
Austria
Prior art keywords
bifunctional
variants
thrombin
urocinase
inhibiting effects
Prior art date
Application number
AT94108872T
Other languages
German (de)
English (en)
Inventor
Gerd Josef Prof Dr Steffens
Stephan Dr Wnendt
Johannes Dr Schneider
Regina Dr Heinzel-Wieland
Derek John Dr Saunders
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of ATE189261T1 publication Critical patent/ATE189261T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT94108872T 1993-07-15 1994-06-09 Bifunktionelle urokinasevarianten mit verbesserten fibrinolytischen eigenschaften und thrombinhemmender wirkung ATE189261T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4323754A DE4323754C1 (de) 1993-07-15 1993-07-15 Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung

Publications (1)

Publication Number Publication Date
ATE189261T1 true ATE189261T1 (de) 2000-02-15

Family

ID=6492909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94108872T ATE189261T1 (de) 1993-07-15 1994-06-09 Bifunktionelle urokinasevarianten mit verbesserten fibrinolytischen eigenschaften und thrombinhemmender wirkung

Country Status (26)

Country Link
US (2) US5681721A (esLanguage)
EP (1) EP0669394B1 (esLanguage)
JP (1) JPH07143878A (esLanguage)
KR (1) KR960014346A (esLanguage)
CN (1) CN1057124C (esLanguage)
AT (1) ATE189261T1 (esLanguage)
AU (1) AU679512B2 (esLanguage)
CA (1) CA2127897A1 (esLanguage)
CZ (1) CZ288536B6 (esLanguage)
DE (2) DE4323754C1 (esLanguage)
DK (1) DK0669394T3 (esLanguage)
ES (1) ES2145075T3 (esLanguage)
FI (1) FI943354L (esLanguage)
GR (1) GR3032488T3 (esLanguage)
HR (1) HRP940366B1 (esLanguage)
HU (1) HU217101B (esLanguage)
IL (1) IL109107A0 (esLanguage)
NO (1) NO941561L (esLanguage)
NZ (1) NZ260991A (esLanguage)
PL (1) PL176971B1 (esLanguage)
PT (1) PT669394E (esLanguage)
RU (1) RU2143490C1 (esLanguage)
SI (1) SI0669394T1 (esLanguage)
SK (1) SK281586B6 (esLanguage)
UA (1) UA27132C2 (esLanguage)
ZA (1) ZA944202B (esLanguage)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
CN1057125C (zh) * 1996-04-26 2000-10-04 南京大学 五种尿激酶变体基因及在大肠杆菌中的表达
CN1111739C (zh) * 1997-02-04 2003-06-18 许文俊 凝血、纤溶功能动态测定试剂
US6503947B1 (en) 1998-01-27 2003-01-07 Brigham And Women's Hospital Method of treating cytotoxic damage
US7498310B1 (en) 1998-08-13 2009-03-03 Beiersdorf Ag Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
AU2001269803A1 (en) * 2000-06-20 2002-01-02 The Trustees Of The University Of Pennsylvania Compositions and methods for modulating muscle cell and tissue contractility
US7361493B1 (en) 2004-05-26 2008-04-22 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Production of urokinase in a three-dimensional cell culture
CN102225966B (zh) 2004-10-19 2012-12-26 隆萨股份公司 用于固相肽合成的方法
CN104193807B (zh) * 2014-09-28 2016-06-15 广州贝奥吉因生物科技有限公司 凝血酶抑制多肽及其制备方法、应用
CN105385617A (zh) * 2015-09-23 2016-03-09 河北省科学院生物研究所 一株产纤溶酶的海洋放线菌株、用途以及由其制备的纤溶酶及纤溶酶的应用
JP2020501561A (ja) 2016-12-16 2020-01-23 ザ・ユニバーシティ・オブ・シドニー 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930944A (en) * 1975-03-31 1976-01-06 Abbott Laboratories Urokinase production
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
WO1989001513A1 (fr) * 1987-08-19 1989-02-23 Sagami Chemical Research Center Prourokinase a action rapide
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
EP0482069A1 (en) * 1989-07-20 1992-04-29 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5328898A (en) * 1990-06-22 1994-07-12 Duke University Factor XIIIA fibrin binding fragments
GB9015369D0 (en) * 1990-07-12 1990-08-29 Erba Carlo Spa Amidated fibrinolytic enzymes and their precursors,and processes for their preparation
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
AU1873092A (en) * 1991-04-09 1992-11-17 Brigham And Women's Hospital Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5571708A (en) * 1993-04-19 1996-11-05 Bristol-Myers Squibb Company Thrombin-activatable plasminogen activator
RU2061043C1 (ru) * 1993-11-16 1996-05-27 Научно-производственная фирма "Нарт" Способ повышения устойчивости урокиназы к нагреванию

Also Published As

Publication number Publication date
RU94026095A (ru) 1997-03-10
UA27132C2 (uk) 2000-02-28
PL176971B1 (pl) 1999-08-31
DE59409104D1 (de) 2000-03-02
US5747291A (en) 1998-05-05
SI0669394T1 (en) 2000-04-30
FI943354A7 (fi) 1995-01-16
US5681721A (en) 1997-10-28
SK281586B6 (sk) 2001-05-10
HK1010109A1 (en) 1999-06-11
EP0669394B1 (de) 2000-01-26
PL304290A1 (en) 1995-01-23
ZA944202B (en) 1995-02-08
NO941561D0 (esLanguage) 1994-04-28
NZ260991A (en) 1995-10-26
FI943354L (fi) 1995-01-16
NO941561L (no) 1995-01-16
CA2127897A1 (en) 1995-01-16
AU6452594A (en) 1995-01-27
RU2143490C1 (ru) 1999-12-27
GR3032488T3 (en) 2000-05-31
HU9402063D0 (en) 1994-09-28
CZ170694A3 (en) 1995-02-15
KR960014346A (ko) 1996-05-22
ES2145075T3 (es) 2000-07-01
HRP940366B1 (en) 2001-02-28
HU217101B (hu) 1999-11-29
DK0669394T3 (da) 2000-05-29
AU679512B2 (en) 1997-07-03
CN1102438A (zh) 1995-05-10
HUT70579A (en) 1995-10-30
EP0669394A1 (de) 1995-08-30
FI943354A0 (fi) 1994-07-14
DE4323754C1 (de) 1994-12-01
IL109107A0 (en) 1994-06-24
CN1057124C (zh) 2000-10-04
SK84594A3 (en) 1995-03-08
CZ288536B6 (cs) 2001-07-11
JPH07143878A (ja) 1995-06-06
HRP940366A2 (en) 1997-04-30
PT669394E (pt) 2000-07-31

Similar Documents

Publication Publication Date Title
NO20064159L (no) Nye, biologisk aktive polypeptider, deres fremstilling og farmasoytiske preparater inneholdende polypeptidene
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE59409104D1 (de) Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
DE60229417D1 (de) Setzungen auf basis von pyrogenisch hergestelltem siliziumdioxid
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ATE416782T1 (de) Medizinische verwendung von il-174 agonisten und antagonisten
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ES2152315T3 (es) Xamoneline tartrato.
ATE98647T1 (de) Substituierte thieno(2,3-b) thiophen-2sulfonamide als mittel gegen glaukoma.
DE68915154D1 (de) Anwendung von gegen retroviren aktiven wirkstoffen und so erhaltene produkte.
ATE194079T1 (de) Verwendung von einer suspension auf der basis von sucralfatgel als antazidum
ES2125849T3 (es) 1-dimetilcarbamoil-3-sustituido-5-sustituido-1h-1,2,4-triazoles.
ES2138653T3 (es) Eteres fenilicos substituidos.
DE68914544D1 (de) Peptid und Wirkstoff gegen Dementia.
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
ATE185273T1 (de) Galenische zubereitungen von molsidomin
YU44594A (sh) Bifunkcionalne varijante urokinaze sa poboljšanim fibrinolitskim svojstvima i delovanjem na suzbijanju trombina
NO922454L (no) Trombolytisk aktivt kombinasjonsprodukt
ATE100330T1 (de) Plasminogenaktivator und thrombolytischer wirkstoff.
WO1991019793A3 (en) Hybrid plasminogen activators
UA26922C2 (uk) Похідhі сульфамідосульфоhілсечовиhи, що мають гербіцидhу активhість,та гербіцидhа композиція hа їх осhові

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee